|Up a level|
Dick, Lindsay J and Gray, Andrew and Ram, Asha and Hume, Aileen and Parris, Caroline and Hogg, Philip J and Elliott, Moira A and Ford, Steven J and Halbert, Gavin W (2013) Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing. Journal of Pharmacy and Pharmacology, 65 (11). 1664–1669.
Halbert, Gavin and Elliott, Moira and Ford, Steven and Dick, Lindsay and Schmidt, Elke (2013) Improved pharmaceutical stability of a boronphenylalanine mannitol formulation for boron neutron capture therapy. European Journal of Pharmaceutical Sciences, 48. pp. 735-739. ISSN 0928-0987
Gray, Andrew and Dick, Lindsay and Elliott, Moira and Ford, Steven and Halbert, Gavin (2012) A comparative analysis of two different analysers used for determination of the Total Organic Carbon in pharmaceutical grade water. European Journal of Parenteral and Pharmaceutical Sciences, 17 (2). pp. 47-51. ISSN 0964-4679
Elliott, Moira and Ford, S J and Prasad, E and Dick, L J and Farmer, H and Hogg, P J and Halbert, G W (2012) Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for phase I clinical trial. International Journal of Pharmaceutics, 426 (1-2). pp. 67-75.
Moore, Barry and Alvarez-Gonzalez, Eva and Alfadhel, Munerah and Mane, Parag and Ford, Steven J. and van der Walle, Christopher F. (2012) Bioprocessing of bacteriophages via rapid drying onto microcrystals. Biotechnology Progress, 28 (2). pp. 540-548. ISSN 8756-7938
Schmidt, Elke and Dooley, Neil and Ford, Steven J. and Elliott, Moira and Halbert, Gavin W. (2012) Physicochemical investigation of the influence of saccharide-based parenteral formulation excipients on l-p-boronphenylalanine solubilisation for boron neutron capture therapy. Journal of Pharmaceutical Sciences, 101 (1). pp. 223-232. ISSN 0022-3549
Dick, Lindsay and Dooley, Neil and Elliott, Moira A and Ford, Steven J and Gordon, Malcolm R and Halbert, Gavin W and Kerr, William J (2011) Boron phenylalanine and related impurities: HPLC analysis, stability profile and degradation pathways. Journal of Pharmaceutical and Biomedical Analysis, 56 (3). pp. 633-636.
Alfadhel, Munerah and Puapermpoonsiri, Utsana and Ford, Steven J. and McInnes, Fiona J. and van der Walle, Christopher F. (2011) Lyophilized inserts for nasal administration harboring bacteriophage selective for Staphylococcus aureus : In vitro evaluation. International Journal of Pharmaceutics, 416 (1). pp. 280-7.
Green, S. and Phoenix, B. and Mill, A. J. and Hill, M. and Charles, M. W. and Thompson, J. and Jones, B. and Ngoga, D. and Detta, A. and James, N. D. and Doran, J. and Graham, N. and Ghani, Z. and Wojnecki, C. and Halbert, G. and Elliott, M. and Ford, S. and Sheehan, T. M. T. and Vickerman, J. and Lockyer, N. and Croswell, G. and Boddy, A. and King, A. and Cruickshank, G. S. (2011) The Birmingham Boron Neutron Capture Therapy (BNCT) project : developments towards selective internal particle therapy. Clinical Oncology, 23 (3). S23-S24. ISSN 0936-6555
Schmidt, E. and Ford, S. and Dooley, N. and Elliot, M. and Halbert, G. (2010) Effects of substituting Fructose by Mannitol in a pharmaceutical formulation. Journal of Pharmacy and Pharmacology, 62 (10). pp. 1428-1429. ISSN 0022-3573
Dooley, N. and Ford, S. J. and Prasad, Elke and Elliott, M. and Halbert, Gavin (2010) Experimental scrutiny and project timelines : an example. Journal of Pharmacy and Pharmacology, 62 (10). pp. 1208-1209. ISSN 0022-3573
Ngoga, D. G. and Cruickshank, G. and Detta, A. and Green, S. and James, N. D. and Wojnecki, C. and Doran, J. and Graham, N. and Ghani, Z. and Halbert, G. and Elliot, M. and Ford, S. and Braithwaite, R. and Sheehan, T. M. T. and Vickerman, J. and Lockyer, N. and Croswell, G. and Sugar, R. and Boddy, A. (2010) Boron Neutron Capture Therapy (BNCT) : clinical optimization of uptake parameters of Boronophenylalanine (BPA). Neuro-Oncology, 12 (3). p. 62. ISSN 1522-8517
Steward, W. P. and Middleton, M. and Benghiat, A. and Loadman, P. M. and Hayward, C. and Waller, S. and Ford, S. and Halbert, G. and Patterson, L. H. and Talbot, D. (2007) The use of pharmacokinetic and pharmacodynamic end points to determine the dose of AQ4N, a novel hypoxic cell cytotoxin, given with fractionated radiotherapy in a phase I study. Annals of Oncology, 18 (6). pp. 1098-1103. ISSN 1569-8041
Ford, S J and Elliott, M A and Halbert, G W (2003) Use of mathematical derivatives (time-domain differentiation) on chromatographic data to enhance the detection and quantification of an unknown 'rider' peak. Journal of Pharmaceutical and Biomedical Analysis, 33 (4). pp. 563-570. ISSN 0731-7085
Elliott, M A and Ford, S J and Walker, A A and Hargreaves, R H J and Halbert, G W (2002) Development of a lyophilised RH1 formulation : a novel DT diaphorase activated alkylating agent. Journal of Pharmacy and Pharmacology, 54 (4). pp. 487-492. ISSN 0022-3573
Conference or Workshop Item
Lord, N. and Ford, S.J. and Elliott, M. and Halbert, G.W. (2016) A quest to find the cause of unknown peaks in cleaning verification chromatography following the manufacture of pharmaceutical preparations. In: 7th APS International PharmSci Conference, 2016-09-05 - 2016-09-07, University of Strathclyde.
Gray, Andrew and Dick, Lindsay and Elliott, Moira and Ford, Steven and Halbert, Gavin (2012) Comparative analysis of TOC and conductivity analysers as applied to pharmaceutical water analysis. In: UK Pharm Sci 2012, 2012-09-12 - 2012-09-14.
Elliott, M. A. and Schmidt, E. and Ford, S. J. and Halbert, G. W. (2010) Experiences of melt fill production of Fenretinide/Lym-X-Sorb (TM) hard gelatin capsules for Phase I clinical trial. In: UNSPECIFIED.